Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One Arm, Open Label,Multi - Center Phase II Study to Evaluate the Safety and Efficacy of IVIG in the Treatment of Various Metastatic Solid Tumors for Which There is no Better Alternate Treatment

NCT00294476 is registered in ClinicalTrials.gov with GammaCan as lead sponsor.

NCT NCT00294476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00294476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One Arm, Open Label,Multi - Center Phase II Study to Evaluate the Safety and Efficacy of IVIG in the Treatment of Various Metastatic Solid Tumors for Which There is no Better Alternate Treatment
Lead sponsor
GammaCan
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2005
Completion date
Not reported
Enrollment
30
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of colon, malignant melanoma, urologic cancer